Mai Peptide
Retatrutide
Finnrick tested 3 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Mai Peptide between 4 Nov 2025 and 23 Nov 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Mai Peptide
Retatrutide
Tested 3 Samples
Last test 23 Nov 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Mai Peptide
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
23 Nov 2025
First
4 Nov 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 23 Nov 2025 | View | 30mg | 31.8mg | +6.0% | 99.80% | October 8, 2025 | No Label / Silver Crimp / Pink Cap | Lab G | Public | |
| 14 Nov 2025 | View | 15mg | 16.4mg | +9.3% | 99.80% | 09/04/2025 | No Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 4 Nov 2025 | View | 10mg | 11.1mg | +11.0% | 99.50% | September 6, 2025 | No Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |